Longwood Fund

Longwood Fund is a Boston, Massachusetts-based venture firm operating in life sciences, where it performs two distinct functions: forming companies around promising technologies and investing in companies through drug development. The firm works with teams turning scientific discoveries into new medicines, with activities spanning company formation, drug development, and clinical development planning, alongside assessment of commercialization prospects for therapeutics.

The firm's stated technical remit covers life sciences venture investing, clinical development planning, and therapeutics commercialization assessment. Sector coverage includes biotechnology and pharmaceuticals, with named areas of interest in oncology, gene therapy, and ophthalmology, as well as technologies originating in academic research. Portfolio support is described as hands-on, extending to the shaping of clinical development plans rather than passive capital allocation.

Longwood Fund maintains a network of leaders across academia, medicine, pharmaceuticals, biotechnology, and venture capital, which it draws on when identifying technologies and assembling teams. The firm positions itself as both a company creator and an investor, with advancement of science into treatments for patients as its stated objective.